Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’
Titel:
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’
Auteur:
Mele, G. Cascavilla, N. Di Renzo, N. Guarini, A. Mazza, P. Melillo, L. Pavone, V. Tarantini, G. Curci, P. Falcone, A. P. Germano, C. Mele, A. Palazzo, G. Palumbo, G. Reddiconto, G. Rossini, B. Specchia, G. Musto, P. Pastore, D.